Seroepidemiological investigation of Crimean Congo hemorrhagic fever virus in livestock in Uganda, 2017.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 09 08 2022
accepted: 01 07 2023
medline: 13 11 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: epublish

Résumé

Crimean-Congo Hemorrhagic fever (CCHF) is an important zoonotic disease transmitted to humans both by tick vectors and contact with fluids from an infected animal or human. Although animals are not symptomatic when infected, they are the main source of human infection. Uganda has reported sporadic human outbreaks of CCHF in various parts of the country since 2013. We designed a nationwide epidemiological study to investigate the burden of CCHF in livestock. A total of 3181 animals were sampled; 1732 cattle (54.4%), 1091 goats (34.3%), and 358 sheep (11.3%) resulting in overall livestock seropositivity of IgG antibodies against CCHF virus (CCHFV) of 31.4% (999/3181). Seropositivity in cattle was 16.9% and in sheep and goats was 48.8%. Adult and juvenile animals had higher seropositivity compared to recently born animals, and seropositivity was higher in female animals (33.5%) compared to male animals (24.1%). Local breeds had higher (36.8%) compared to exotic (2.8%) and cross breeds (19.3%). Animals that had a history of abortion or stillbirth had higher seropositivity compared to those without a history of abortion or stillbirth. CCHFV seropositivity appeared to be generally higher in northern districts of the country, though spatial trends among sampled districts were not examined. A multivariate regression analysis using a generalized linear mixed model showed that animal species, age, sex, region, and elevation were all significantly associated with CCHFV seropositivity after adjusting for the effects of other model predictors. This study shows that CCHFV is actively circulating in Uganda, posing a serious risk for human infection. The results from this study can be used to help target surveillance efforts for early case detection in animals and limit subsequent spillover into humans.

Identifiants

pubmed: 37943886
doi: 10.1371/journal.pone.0288587
pii: PONE-D-22-22276
pmc: PMC10635543
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0288587

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist

Références

Acta Trop. 2019 Aug;196:102-120
pubmed: 31108083
Microorganisms. 2021 Feb 20;9(2):
pubmed: 33672497
Int J Infect Dis. 2011 Jul;15(7):e449-52
pubmed: 21511509
PLoS Negl Trop Dis. 2016 Jan 07;10(1):e0004210
pubmed: 26741652
Clin Microbiol Infect. 2006 Jun;12(6):551-4
pubmed: 16700704
J Infect. 2022 Dec;85(6):683-692
pubmed: 36152736
Int J Infect Dis. 2018 Mar;68:88-93
pubmed: 29382607
PLoS Negl Trop Dis. 2022 Mar 21;16(3):e0010217
pubmed: 35312678
Iran J Parasitol. 2011 Aug;6(3):113-5
pubmed: 22347306
Lancet Infect Dis. 2018 Apr;18(4):373-375
pubmed: 29582758
Am J Trop Med Hyg. 2021 Oct 18;106(1):88-98
pubmed: 34662872
Vector Borne Zoonotic Dis. 2021 Oct;21(10):809-816
pubmed: 34559011
Antiviral Res. 2018 Mar;151:24-26
pubmed: 29330092
Viruses. 2019 Jun 28;11(7):
pubmed: 31261754
PLoS Negl Trop Dis. 2021 May 28;15(5):e0009384
pubmed: 34048430
Jpn J Infect Dis. 2015;68(2):131-4
pubmed: 25420643
Vector Borne Zoonotic Dis. 2020 Oct;20(10):797-799
pubmed: 32429789
Prev Vet Med. 1997 Jul;31(1-2):147-50
pubmed: 9234433
Prev Vet Med. 2006 Aug 17;75(3-4):251-66
pubmed: 16797092
Emerg Infect Dis. 2022 Nov;28(11):2326-2329
pubmed: 36198315
Ticks Tick Borne Dis. 2018 May;9(4):945-955
pubmed: 29606621
Int J Infect Dis. 2021 Aug;109:174-181
pubmed: 34242761
PLoS Negl Trop Dis. 2021 Mar 8;15(3):e0009213
pubmed: 33684124
J Virol Methods. 2021 Apr;290:114075
pubmed: 33515661
Prev Vet Med. 2022 Sep;206:105708
pubmed: 35835047
Parasit Vectors. 2020 Apr 3;13(1):165
pubmed: 32245511
Virol J. 2013 Jun 05;10:178
pubmed: 23738961

Auteurs

Luke Nyakarahuka (L)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.
Department of Biosecurity, Ecosystems and Veterinary Public Health, College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.

Jackson Kyondo (J)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Carson Telford (C)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Amy Whitesell (A)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Alex Tumusiime (A)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Sophia Mulei (S)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Jimmy Baluku (J)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Caitlin M Cossaboom (CM)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Deborah L Cannon (DL)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Joel M Montgomery (JM)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Julius J Lutwama (JJ)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

Stuart T Nichol (ST)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Stephen K Balinandi (SK)

Department of Arbovirology, Emerging and Reemerging Infectious Diseases, Uganda Virus Research Institute, Entebbe, Uganda.

John D Klena (JD)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Trevor R Shoemaker (TR)

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH